Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
18.83B
Market cap18.83B
Price-Earnings ratio
22.62
Price-Earnings ratio22.62
Dividend yield
Dividend yield
Average volume
1.40M
Average volume1.40M
High today
$126.11
High today$126.11
Low today
$121.95
Low today$121.95
Open price
$121.98
Open price$121.98
Volume
1.39M
Volume1.39M
52 Week high
$155.53
52 Week high$155.53
52 Week low
$68.70
52 Week low$68.70

Stock Snapshot

The current Illumina(ILMN) stock price is $123.45, with a market capitalization of 18.83B. The stock trades at a price-to-earnings (P/E) ratio of 22.62.

During the trading session on 2026-04-01, Illumina(ILMN) shares reached a daily high of $126.11 and a low of $121.95. At a current price of $123.45, the stock is +1.2% higher than the low and still -2.1% under the high.

Trading activity shows a volume of 1.39M, compared to an average daily volume of 1.4M.

The stock's 52-week range extends from a low of $68.70 to a high of $155.53.

The stock's 52-week range extends from a low of $68.70 to a high of $155.53.

ILMN News

Simply Wall St 15h
Illumina Valuation Check As Labcorp Partnership Expands In Precision Oncology

Illumina (ILMN) just expanded its collaboration with Labcorp, centering investor attention on how next generation sequencing in precision oncology might influen...

Illumina Valuation Check As Labcorp Partnership Expands In Precision Oncology

Analyst ratings

48%

of 23 ratings
Buy
47.8%
Hold
39.1%
Sell
13%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.